has granted Clinical Trial Application (CTA) approval for the first-in-human Phase I/IIa clinical trial of ITOP1, the company's lead 'off-the-shelf' cancer vaccine. ITOP1 is a precision cancer ...

Clinical trials are most successful when the participants ... it now plays a central role in bridging the gap between research and clinical application. The importance of biosimilars only ...

WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) has announced that the U.S. Food and Drug Administration (FDA) has ...

has approved the Clinical Trial Application (CTA) for IOMX-0675, a LILRB1/LILRB2 cross-specific antibody designed to reverse immune suppression in solid tumors. The phase I/IIa clinical trial will ...

Lynae Darbes, PhD, discusses what her research results mean when it comes to implementation of self-testing and counselling ...

Shares of Aclaris Therapeutics were trading higher after the company said regulators had cleared its new drug application for a trial of ATI-052, its potential treatment for immuno-inflammatory ...

KYOTO—Researchers have safely transplanted nerve cells generated from induced pluripotent stem (iPS) cells into the brains of ...

The first-ever analysis of the UK clinical trial landscape by the Medicines and Healthcare products Regulatory Agency (MHRA) and the University of Liverpool reveals the UK is a global leader in ...